Hypervolemic treatment in acute non-arteriitic aio

Not Applicable

• Conditions: H47.0; Disorders of optic nerve, not elsewhere classified

• Registration Number: DRKS00012603
• Lead Sponsor: niklinik RWTH Aachen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2004-10-15
• Study Start: 2017-07-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Acute non-arteriitic AIO

Exclusion Criteria

arteriitic AIO

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Perfusionparameters (Peak-systolic (PSV) and end-diastolic velocities (EDV) and Pourcelot´s resistive index (RI) are measured in the ophthalmic artery (OA), central retinal artery (CRA) and the short posterior ciliary arteries (PCA)) measured via Colour Doppler Imaging (CDI) prior and after infusion of HES. An increased blood flow is expected after infusion of HES.